CONTEXT
In the context of medically assisted procreation the Intra Cytoplasmic Sperm Injection success rates are around 20%. These low success rates can be explained by the lack of objective criteria during oocytes selection. Indeed, clinicians select them through morphological visual criteria, which depend only on their skills and experience.
DESCRIPTION
Added stage to existing ICSI platform that provides precise oocytes mechanical properties in order to select the best oocyte to be fertilized, best ICSI timing and embryo transfer.
Completed developments:
- Automation of oocyte mechanical characterization (quantitative data) in the medically assisted reproduction center of Besancon
- Measurement of absolute values based on a standard calibration method
- Production of a prototype platform
Current developments:
- Consolidation of mechanical characterization data of oocytes in medically assisted procreation center
Upcoming development:
- Correlation of the mechanical behavior of an oocyte with the probability of achieving pregnancy
- First clinical trials on oocytes intended to be fertilized
COMPETITIVE ADVANTAGES
MARKETS AND APPLICATIONS
Medically assisted reproduction market
DEVELOPMENT STAGE
Prototype undergoing validation in a representative environment(TRL 5-6)
RESEARCH TEAM
FEMTO-ST Institute
Franche-Comté University - CNRS
INTELLECTUAL PROPERTY
Patent ID : WO 2018172688
Applications in Europe, Canada, China, India and Japan
TARGET PARTNERSHIP
Co-development of technology to meet the manufacturer’s needs
CONTACT
Thomas BLUM
Business Developer
+33 (0)6 17 06 68 07
thomas.blum@sayens.fr